Sign in

Charles Gregory Peters

Managing Director and Senior Equity Research Analyst at Raymond James

Charles Gregory Peters is a Managing Director and Senior Equity Research Analyst at Raymond James Financial, specializing in insurance sector coverage with a particular focus on life/health, property/casualty, insurance brokerage, and related technology companies. He actively covers 15 major publicly traded firms, including Progressive, Kemper, Mercury General, Old Republic International, and Willis Towers Watson, with a ratings history dominated by Strong Buy and Buy recommendations. Peters began his analyst career with Everen Securities and ABN AMRO Inc., joined Raymond James in 1999, rejoined the Equity Research group in 2009, and also co-founded Skyward Specialty Insurance (SKWD), serving as its president and holding board positions in the industry. He holds an MBA from DePaul University’s Kellstadt Graduate School of Business, a bachelor’s from Drake University, serves as chairperson of the CFA Society of New York’s Annual Insurance Conference, and possesses advanced knowledge of industry regulation and financial analysis.

Charles Gregory Peters's questions to EVEREST GROUP (EG) leadership

Question · Q3 2025

Charles Gregory Peters questioned Everest Group's confidence in its casualty reserves within the reinsurance business, especially following the cleanup of its insurance operations. He also asked about the outlook for property reinsurance pricing conditions in 2026, considering a 'light year' and increasing PMLs.

Answer

Jim Williamson, President and CEO, differentiated the portfolios, stating the insurance book was 'bottom quartile' while reinsurance is 'top quartile' with consistent disciplined underwriting. Regarding property reinsurance, Mr. Williamson noted a still favorable environment despite likely 10% price decreases at 1/1/2026, emphasizing selectivity and long-term strategy over short-term market reactions.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts